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 Celiac disease (CD) is a chronic immune-mediated disorder, characterized by villus 
atrophy of the proximal small intestinal mucosa and malabsorption of nutrients after the 
ingestion of wheat gluten or related proteins from rye and barley, in genetically susceptible 
individuals expressing the HLA class II molecules DQ2 or DQ8.  
When gluten is ingested, it is broken down into peptides, particularly gliadin. It is thought 
that gliadin binds to antigen-presenting cells expressing HLA-DQ2 and HLADQ8. This event 
is facilitated by the enzyme ‘‘tissue transglutaminase’’. The peptides are then presented to 
intestinal mucosal T-lymphocytes which become activated, producing antibodies and 
cytokines, resulting in inflammation and intestinal mucosal injury. 
Serum IgA EMA (endomysial antibody), IgA tTG (tissue transglutaminase antibody) and 
small bowel biopsy are the accepted tests to diagnose CD. 
In the last decades, screening studies have shown a higher prevalence of CD than previously 
thought; up to 1% of the European and US population are affected at any age and in a wide 
variety of clinical circumstances.  
In the past, CD was almost always recognized because of its classical presentation, seen 
mainly in children, characterized by a predominance of digestive symptoms like diarrhea, 
weight loss, and growth retardation. Today, the presentation of CD is more frequently 
atypical, with confusing symptoms or without symptoms at all. These latter forms may 
remain undiagnosed for years. The clinical manifestations of the disease vary greatly, and 
range from typical gastrointestinal manifestations (steatorrhea, vomiting, abdominal pain, 
diarrhea, muscle wasting, nutritional deficiencies) to absent, minimal, or unusual intestinal 
complaints with extraintestinal manifestations or disorders (atypical CD); the definition of 
silent CD includes a fully expressed gluten-sensitive enteropathy found after serologic 
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screening in asymptomatic patients [1]. Several extraintestinal manifestations, including 
anemia and osteopenia have been associated to CD [2]. 
Of note, CD patients can be overweight and obese: one study from the Northeast US found 
that 32% of patients with CD were overweight or obese at presentation, whereas only 6.8% of 
these were underweight [3]. 
 In a recent interesting study, the authors [4] examined, preoperatively, the prevalence 
of micronutrient deficiency in patients with morbid obesity, in order to evaluate the need for  
nutritional counseling and appropriate substitution. In this cross-sectional, retrospective 
study, conducted at the Rudolfstiftung Hospital, Vienna, Austria between 2010 and 2015, 
1732 Caucasian patients with morbid obesity (77.3% women, mean age: 40 ± 12 years, mean 
BMI: 44 ± 9 kg/m2) wishing to undergo bariatric surgery were enrolled. Patients aged < 18 
years or > 60 years as well as pregnant women were excluded from evaluation. The authors 
demonstrated a high prevalence of micronutrient deficiencies. In particular, 97.5% of patients 
exhibited a deficiency in 25OHvitamin D, and 30.2% an elevated level of parathyroid 
hormone. These conditions are known to be associated with metabolic bone disease and 
osteoporosis. The authors tried to explain these results with the fact that patients with morbid 
obesity had a sedentary lifestyle and thus potentially less sun exposure. Furthermore, since 
people with morbid obesity tend to consume less milk, the authors hypothesized a minor 
intake of vitamin D. In addition, vitamin D is sequestered in the large pool of body fat, and 
therefore, its bioavailability is reduced. Moreover, a total of 63.2% of the patients had a 
deficit in folic acid and 9.6% in serum iron: this resulted in anemia in 10.8% of women vs. 
3.1% of men. Folic acid is prevalent in leafy vegetables, whole meal products, and legumes 
and is characterized by a low storage capacity; iron is prevalent in meat, whole meal 
products. The authors hypothesized that low plasma levels were most likely due to decreased 
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consumption of the respective nutrients. However, in this paper, it is not reported if the 
authors have searched for CD. 
Since CD is an important cause of 25OH-vitamin D, folic acid and iron malabsorption, its 
prevalence is constantly increasing but only about 1 of 5 CD patients are currently diagnosed 
and up to 32% of the patients with CD are overweight or obese at presentation, the search for 
CD in case of micronutrient deficiency is mandatory. Measurement of serum IgA EMA or 
IgA tTG anti-gliadin should be performed in this context even if the patients are obese: 
antibody-positive patients should be offered a duodenal biopsy. 
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